Indication
Microscopic polyangiitis
Microscopic polyangiitis is a rare, systemic autoimmune disease characterized by necrotizing vasculitis that predominantly targets small-caliber blood vessels, including arterioles, capillaries, and venules. Read more about Microscopic polyangiitis
4 drugs 4 manufacturers
Drugs that treat it
Common Microscopic polyangiitis therapies.
RUXIENCE (rituximab-pvvr)
RIABNI (rituximab-arrx)
TAVNEOS (avacopan)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMicroscopic polyangiitis is a rare, systemic autoimmune disease characterized by necrotizing vasculitis that predominantly targets small-caliber blood vessels, including arterioles, capillaries, and venules.
As a form of antineutrophil cytoplasmic antibody-associated vasculitis, it classically demonstrates pauci-immune vascular inflammation—marked by minimal or absent immune deposit formation—and most frequently associates with circulating myeloperoxidase-specific autoantibodies.
Although the condition can affect individuals of any age across diverse organ systems, it most commonly presents in middle-aged to older adults with rapidly progressive glomerulonephritis, alveolar hemorrhage secondary to pulmonary capillaritis, systemic constitutional symptoms, and peripheral neuropathy.
Unlike related vasculitides, microscopic polyangiitis is histopathologically defined by the absence of granulomatous inflammation.
- nih.gov
Microscopic polyangiitis is a rare, systemic autoimmune disease characterized by necrotizing vasculitis that predominantly targets small-caliber blood vessels, including arterioles, capillaries, and venules As a form of antineutrophil cytoplasmic antibody-associated vasculitis, it classically demonstrates pauci-immune vascular inflammation—marked by minimal or absent immune deposit formation—and most frequently associates with circulating myeloperoxidase-specific autoantibodies
- merckmanuals.com
Microscopic polyangiitis is a rare, systemic autoimmune disease characterized by necrotizing vasculitis that predominantly targets small-caliber blood vessels, including arterioles, capillaries, and venules As a form of antineutrophil cytoplasmic antibody-associated vasculitis, it classically demonstrates pauci-immune vascular inflammation—marked by minimal or absent immune deposit formation—and most frequently associates with circulating myeloperoxidase-specific autoantibodies Although the cond...
- nih.gov
As a form of antineutrophil cytoplasmic antibody-associated vasculitis, it classically demonstrates pauci-immune vascular inflammation—marked by minimal or absent immune deposit formation—and most frequently associates with circulating myeloperoxidase-specific autoantibodies
- nih.gov
Although the condition can affect individuals of any age across diverse organ systems, it most commonly presents in middle-aged to older adults with rapidly progressive glomerulonephritis, alveolar hemorrhage secondary to pulmonary capillaritis, systemic constitutional symptoms, and peripheral neuropathy
- hopkinsvasculitis.org
Although the condition can affect individuals of any age across diverse organ systems, it most commonly presents in middle-aged to older adults with rapidly progressive glomerulonephritis, alveolar hemorrhage secondary to pulmonary capillaritis, systemic constitutional symptoms, and peripheral neuropathy
- nih.gov
Although the condition can affect individuals of any age across diverse organ systems, it most commonly presents in middle-aged to older adults with rapidly progressive glomerulonephritis, alveolar hemorrhage secondary to pulmonary capillaritis, systemic constitutional symptoms, and peripheral neuropathy
- nih.gov
Unlike related vasculitides, microscopic polyangiitis is histopathologically defined by the absence of granulomatous inflammation
Personalize your experience
Follow Microscopic polyangiitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.